When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KROS - Keros Therapeutics GAAP EPS of -$1.01 misses by $0.15
Keros Therapeutics Inc.
Keros Therapeutics press release (NASDAQ:KROS): Q1 GAAP EPS of -$1.01 misses by $0.15. Keros’ cash and cash equivalents as of March 31, 2022 was $228.6 million compared to $230.0 million as of December 31, 2021. Keros expects that the cash and cash equivalents it had on hand at March 31, 2022 will fund its operating expenses and capital expenditure requirements into the first quarter of 2024.